Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company specializing in rare neuroendocrine diseases. They are focused on developing innovative medicines and supporting healthcare providers and patients, with a strong commitment to transforming patient lives on a global scale.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
106% above the average for this role
National Account Director
Arrowhead Pharmaceuticals
National Account Director
Arrowhead Pharmaceuticals
Corporate Account Director - West Region
Dyne Therapeutics
Senior Director, Market Access Spain & Portugal
Cytokinetics
National Account Director
Arrowhead Pharmaceuticals
Associate Principal - Analytics
Blue Matter